Editor’s Note: In the original video, a statement was inaccurately attributed. We regret the error OKLAHOMA CITY (KFOR) — ...
Among patients with moderate to severe atopic dermatitis, APG777 produced significant reductions in disease severity at 16 weeks.
Investigators assessed whether exposure to O3, NO2, and fine particulate matter independently contributes to increased asthma exacerbation risk. Patients with mild asthma in the highest vs lowest ...
If approved, Dupixent would be the first targeted medicine in the EU indicated for children aged 2 to 11 years with CSU inadequately controlled by standard-of-care antihistamine treatment CSU is a ...
--Regeneron Pharmaceuticals, Inc. and Sanofi today announced that the U.S. Food and Drug Administration has approved Dupixent ® for the treatment of adult and pediatric patients aged 6 years and older ...
Background We describe the epidemiology of asthma, chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) from 2004 to 2023 in England, Wales, Scotland and Northern Ireland ...
CAMBRIDGE, Mass., Feb. 17, 2026 /PRNewswire/ -- Sanofi today announced the appointment of Manuela Buxo as Head of Specialty Care, effective March 1, 2026. Manuela will succeed Brian Foard, who has ...
dNational Institute for Health and Care Research, Cambridge Biomedical Research Centre, Addenbrooke's Hospital, Cambridge, UK eWellcome-Wolfson Institute for Experimental Medicine, School of Medicine, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results